Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline

Cancer

Volumn 124, Issue 14, 2018, Pages 2974-2985

  Meester, Reinier G S ^a,b   Peterse, Elisabeth F P ^a   Knudsen, Amy B ^c   de Weerdt, Anne C ^a   Chen, Jennifer C ^d   Lietz, Anna P ^c   Dwyer, Andrea ^e,f   Ahnen, Dennis J ^e,g   Siegel, Rebecca L ^h   Smith, Robert A ^h   Zauber, Ann G ^d   Lansdorp Vogelaar, Iris ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^f Fight Colorectal Cancer (Fight CRC)   (United States)

^g University of the Rockies   (United States)

^h AMERICAN CANCER SOCIETY   (United States)

Author keywords

colorectal neoplasms; decision modeling; early detection of cancer; guidelines; personalized medicine

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER INCIDENCE; CANCER MODEL; CANCER RISK; CANCER SCREENING; CAUCASIAN; COLONOGRAPHY; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE BURDEN; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE AGED; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RACE; REFERENCE VALUE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SEX; SIMULATION; TREND STUDY; UNITED STATES; AFRICAN AMERICAN; AGE; BIOLOGICAL MODEL; CANCER REGISTRY; CAUSE OF DEATH; COLORECTAL TUMOR; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; EARLY CANCER DIAGNOSIS; HEALTH DISPARITY; MASS SCREENING; NON PROFIT ORGANIZATION; PROCEDURES; SEX FACTOR; SURVIVAL RATE;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AMERICAN CANCER SOCIETY; CAUSE OF DEATH; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SEER PROGRAM; SEX FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 85047834316     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31542     Document Type: Article

References (46)

1. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177-193.
2. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
3. Eddy D. ACS report on the cancer-related health checkup. CA Cancer J Clin. 1980;30:193-240.
4. Arias E, Heron M, Jiaquan X. United States life tables, 2013. Natl Vital Stat Rep. 2017;66:1-64.
5. Saini SD, van Hees F, Vijan S. Smarter screening for cancer: possibilities and challenges of personalization. JAMA. 2014;312:2211-2212.
6. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739-750.
7. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153:307-323.
8. Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564-2575.
9. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130-160.
10. Peterse EFP, Meester RGS, Siegel RL, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124.
11. Murphy CC, Lund JL, Sandler RS. Young-onset colorectal cancer: earlier diagnoses or increasing disease burden? Gastroenterology. 2017;152:1809-1812.
12. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659-669.
13. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA. 2016;315:2595-2609.
14. U.S. Preventive Services Task Force. Modeling report. https://www.uspreventiveservicestaskforce.org/Page/Document/modeling-report1/colorectal-cancer-screening2. Accessed March 6, 2017.
15. Cancer Intervention and Surveillance Modeling Network. Colorectal cancer model profiles. https://cisnet.cancer.gov/colorectal/profiles.html/. Accessed January 1, 2017.
16. Arminski TC, McLean DW. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964;7:249-261.
17. Blatt LJ. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum. 1961;4:277-282.
18. Bombi JA. Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer. 1988;61:1472-1476.
19. Chapman I. Adenomatous polypi of large intestine: incidence and distribution. Ann Surg. 1963;157:223-226.
20. Clark JC, Collan Y, Eide TJ, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer. 1985;36:179-186.
21. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut. 1992;33:1508-1514.
22. Johannsen LG, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol. 1989;24:799-806.
23. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979;43:1847-1857.
24. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49:819-825.
25. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23:835-842.
26. Surveillance, Epidemiology, and End Results Program. SEER*Stat Database: incidence—SEER 9 regs research data, Nov 2013 sub (1973-2011) —linked to county attributes—total U.S., 1969-2012 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission. https://seer.cancer.gov/data/. Accessed May 25, 2016.
27. Rutter CM, Johnson EA, Feuer EJ, Knudsen AB, Kuntz KM, Schrag D. Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst. 2013;105:1806-1813.
28. Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849-857.
29. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95:230-236.
30. van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG. Should colorectal cancer screening be considered in elderly persons without previous screening?: a cost-effectiveness analysis. Ann Intern Med. 2014;160:750-759.
31. Rutter CM, Knudsen AB, Marsh TL, et al. Validation of models used to inform colorectal cancer screening guidelines: accuracy and implications. Med Decis Making. 2016;36:604-614.
32. Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312:606-615.
33. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial—SCORE. J Natl Cancer Inst. 2011;103:1310-1322.
34. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109:djw322.
35. Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016;111:1092-1101.
36. Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110:72-90.
37. Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150:17-22.
38. Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, et al. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making. 2011;31:530-539.
39. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997;126:811-822.
40. National Center for Health Statistics. 2010, 2013, and 2015 National Health Interview Survey. http://www.cdc.gov/nchs/nhis.htm. Accessed January 26, 2018.
41. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, et al. Individualizing colonoscopy screening by sex and race. Gastrointest Endosc. 2009;70:96-108.
42. van Hees F, Saini SD, Lansdorp-Vogelaar I, et al. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology. 2015;149:1425-1437.
43. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575-582.
44. Liang PS, Dominitz JA. Bowel preparation: is fair good enough? Am J Gastroenterol. 2014;109:1725-1727.
45. Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med. 2016;164:456-463.
46. Winawer SJ, Fischer SE, Levin B. Evidence-based, reality-driven colorectal cancer screening guidelines: the critical relationship of adherence to effectiveness. JAMA. 2016;315:2065-2066.